International Edition
Latest News
Health

Stem Cell Autograft: Procedure, Indications, Recovery & Long-Term Follow-Up

At Hôpital Koru, clinicians are utilizing stem cell autografting to push the boundaries of chemotherapy, according to Koruhospital. By harvesting a patient’s own hematopoietic cells before treatment, the facility performs a "rescue" procedure that restores blood cell production…

Stem Cell Autograft: Procedure, Indications, Recovery & Long-Term Follow-Up

At Hôpital Koru, clinicians are utilizing stem cell autografting to push the boundaries of chemotherapy, according to Koruhospital.

By harvesting a patient’s own hematopoietic cells before treatment, the facility performs a “rescue” procedure that restores blood cell production after high-dose therapy—doses that would otherwise be lethal to the bone marrow.

“The goal of the treatment is not to replace a diseased marrow with a healthy one from another person, as in an allograft, but to allow a stronger attack against the disease than usual doses permit,” according to Hôpital Koru.

The procedure functions less like a surgical operation and more like a blood transfusion. The clinical sequence begins with mobilization injections, where medication stimulates the bone marrow to produce an abundance of white blood cells and releases the anchors holding stem cells in place, allowing them to enter the bloodstream. Laboratories then identify these stem cells using a surface marker called CD34, and the number of CD34-positive cells collected determines if the quantity is sufficient for a transplant.

Following this, apheresis is used to collect the cells, which are stored in liquid nitrogen at approximately -196 degrees Celsius. Once the patient completes high-dose conditioning chemotherapy and the drug clears from the body—a milestone known as “day zero”—the thawed stem cells are infused via a central venous catheter. This same catheter serves as the primary access point for medication and blood draws throughout the hospital stay.

While autografts eliminate the rejection risks inherent in donor-derived transplants, the process remains physically demanding. Patients spend the recovery period in a protected room, where they remain vulnerable to bleeding, mouth sores, and infections while blood cell counts are at their lowest.

Hôpital Koru instructs patients to contact the transplant unit immediately if they develop a fever of 38 degrees Celsius or higher, warning that infections during this window can escalate rapidly.

The therapy is primarily indicated for multiple myeloma and certain lymphomas. Less frequently, it is applied to amyloidosis, specific pediatric solid tumors, germ cell tumors, and select autoimmune diseases, though these cases are managed in specialized centers.

Recovery of immunity and energy typically spans several months. Long-term follow-up is essential, as the high-dose chemotherapy can erase prior immune memory. Patients must undergo a vaccination schedule similar to childhood programs, typically starting three to six months after the transplant, while also being monitored for hormonal shifts and secondary cancers.

“The decision is always individual and takes into account the patient’s priorities as much as medical results,” Hôpital Koru said.

According to the hospital’s hematology team, clinicians explain why a graft is recommended, what benefit it provides beyond previous treatments, and what alternatives exist. These options include continuing treatment without high-dose chemotherapy or, where appropriate, utilizing new cellular and targeted therapies.

About the author: Health Desk

Health Desk at Archynewsy.